RT null
T1 Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies
A1 D’Orazi G., 
A1 Cordani M., 
A1 Cirone M., 
YR 2020
FD 2020
LK http://hdl.handle.net/20.500.12614/1463
UL http://hdl.handle.net/20.500.12614/1463
LA en
DS Repositorio institucional de IMDEA Nanociencia
RD 16 may. 2026